US Stocks
/
Pharvaris N.V. Share Price

Pharvaris N.V. Share Price

NASDAQ: PHVS
$31.45
+$0.32 (1.03%) Last updated on 09 Oct, 2026 | 21:14 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Pharvaris N.V. Stock Performance

Open
$31.21
Prev. Close
$31.13
Circuit Range
N/A
Day Range
$31.21 - $31.89
Year Range
$20.92 - $43.03
Volume
10,325
Average Traded
$31.58

Pharvaris N.V. Share Price Today

As of 9 October 2026, Pharvaris N.V.'s share price is $31.45. The stock opened at $31.21, compared to its previous close of $31.13. During today's trading session, Pharvaris N.V.'s share price traded between $31.21 and $31.89, with an average price of $31.55. Over the past 52 weeks, the stock has recorded a high of $43.03 and a low of $20.92. In terms of performance, Pharvaris N.V.'s share price has risen by 1.34% over the last six months and is up 41.60% on a year-on-year basis.

Pharvaris N.V. Share Price Chart

$31.21$31.89
L
Show Current Price
H

Pharvaris N.V. Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$0.00
Return On Equity (TTM)
N/A
Profit Margin
N/A
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

Pharvaris N.V. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$81.86-$111.58-$139.51-$206.62
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-36.31%-25.03%-48.10%

About Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks. The company is also running open-label extension studies in both on-demand (RAPIDe-2) and prophylactic (CHAPTER-4) settings to collect long-term safety and efficacy data in HAE patients.

Pharvaris N.V. Historical Returns

MonthOpenCloseChange %
Oct 2026
$31.57
$31.33
-1.43%
Sep 2026
$34.02
$31.79
-14.16%
Aug 2026
$32.34
$37.03
+13.59%
Jul 2026
$34.20
$32.60
-5.51%
Jun 2026
$29.47
$34.50
+14.39%
May 2026
$30.69
$30.16
-2.82%
Apr 2026
$27.78
$31.04
+9.92%
Mar 2026
$28.36
$28.23
-0.49%
Feb 2026
$27.89
$28.38
+4.84%
Jan 2026
$27.70
$27.07
-2.45%
Dec 2025
$28.39
$27.75
-1.89%
Nov 2025
$22.63
$28.28
+27.33%

PHVS Share Price FAQs

What is Pharvaris N.V. share price today?

chevron-up
Pharvaris N.V. share price today is $31.45 as on October 9, 2026 at 9:14 pm IST.

What is the 52 week high and 52 week low of Pharvaris N.V. stock?

chevron-up
The 52 week high of Pharvaris N.V. stock is $43.03, while the 52 week low is $20.92 as of 9 Oct '26.

What is the 5 year returns of PHVS?

chevron-up
The 5 year returns of PHVS is 81.27% as on 9 Oct '26.

What is the high & low stock price of PHVS today?

chevron-up
PHVS stock price hit a high of $31.89 and low of $31.21 as of 9 Oct '26.

Can I buy PHVS shares in India?

chevron-up
Yes. You can buy PHVS in India by opening an international trading account.